Effect of Unani Medicine Coded Formulations for the Management of Anomalies Associated With Polycystic Ovarian Syndrome
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 150
- 试验地点
- 1
- 主要终点
- Improvement in the menstrual regularity of the patient
研究概览
简要总结
Currently available medications for PCOS are symptom(s) oriented but have limitations because of its complex pathophysiology. The most preferred drug against PCOS is metformin which act as an insulin sensitizer to improve insulin-glucose metabolism and anovulatory cycles in PCOS. However, its use is associated with various side effects such as bloating, diarrhea and nausea. Thus, it is imperative to explore various other alternatives to combat this gynecological problem.
详细描述
Polycystic ovarian syndrome (PCOS) is a common endocrine disorder in reproductive age women, with a prevalence between 5%-15%. Currently, sedentary lifestyle, excessive intake of junk food and increasing prevalence of obesity has been associated with rise in the incidence of PCOS.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 38 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
Control group
metformin 500 mg twice a day
干预措施: Metformin (Drug)
Picolin group
Picolin 500mg thrice a day
干预措施: Metformin (Drug)
Rasoline
Rasoline 500mg thrice a day
干预措施: Metformin (Drug)
结局指标
主要结局
Improvement in the menstrual regularity of the patient
时间窗: 1 year
The lengths and duration of menstrual cycle of patients will be measured
次要结局
未报告次要终点
研究者
Leena Hameed
Assistant professor
Hamdard University